person

Carmen H.

Country
Spain
Department
Medical Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
52
Sites with multiple studies

Has run more than one trial at 52 of 235 partner sites.

Specializations

Hormone Receptor-Positive Breast Cancer

The investigator specializes in treating ER-positive/HER2-negative breast cancer, with particular focus on advanced and early-stage disease management. Their research encompasses innovative therapeutic approaches including extended endocrine therapy and novel drug combinations.

  • Early-stage breast cancer treatment optimization
  • Advanced hormone-positive disease management
  • Endocrine therapy resistance

Key interests include evaluating targeted therapies and exploring treatment strategies for patients with endocrine-resistant disease.

Triple-Negative Breast Cancer

The investigator conducts research in triple-negative breast cancer (TNBC) treatment, focusing on both metastatic and locally advanced disease. Their work includes evaluation of immunotherapy combinations and novel therapeutic approaches.

  • Metastatic TNBC treatment
  • Immunotherapy combinations
  • Post-neoadjuvant therapy strategies

Special attention is given to developing treatments for patients with residual disease after surgery and initial therapy.

Advanced Breast Cancer

The investigator focuses on treating advanced breast cancer with molecular alterations, including PIK3CA/PTEN mutations and ESR1 mutations. Their research encompasses innovative combination approaches and targeted therapies.

  • Molecular-targeted therapies
  • Treatment resistance mechanisms
  • Novel drug combinations

Areas of expertise include developing treatments for patients who have progressed on standard therapies.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.